Literature DB >> 2507374

Direct effects of estrogen on c-fos and c-myc protooncogene expression and cellular proliferation in human breast cancer cells.

B van der Burg1, A J van Selm-Miltenburg, S W de Laat, E J van Zoelen.   

Abstract

Estrogen induces DNA synthesis to a lesser degree, but with similar kinetics compared to insulin-like growth factors when added to quiescent MCF7 human breast cancer cells. Moreover, this steroid rapidly induces expression of the growth-related c-fos and c-myc protooncogenes. The induction was shown to be a direct effect, independent of protein synthesis. These results demonstrate that no growth factor production is involved in estrogen-induced protooncogene expression, and that these direct effects on gene expression may be an important step in estrogen-induced mitogenesis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2507374     DOI: 10.1016/0303-7207(89)90149-4

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  18 in total

1.  Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor alpha, epidermal growth factor receptor, c-fos, and c-myc genes.

Authors:  E A Musgrove; C S Lee; R L Sutherland
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

Review 2.  Genesis of prolactinomas: studies using estrogen-treated animals.

Authors:  Dipak K Sarkar
Journal:  Front Horm Res       Date:  2006       Impact factor: 2.606

3.  Estrogen deficiency reversibly induces telomere shortening in mouse granulosa cells and ovarian aging in vivo.

Authors:  Sharyn Bayne; He Li; Margaret E E Jones; Alex R Pinto; Michelle van Sinderen; Ann Drummond; Evan R Simpson; Jun-Ping Liu
Journal:  Protein Cell       Date:  2011-05-15       Impact factor: 14.870

4.  Role of proliferation and apoptosis in net growth rates of human breast cancer cells (MCF-7) treated with oestradiol and/or tamoxifen.

Authors:  P E Budtz
Journal:  Cell Prolif       Date:  1999-10       Impact factor: 6.831

5.  PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells.

Authors:  G Castoria; A Migliaccio; A Bilancio; M Di Domenico; A de Falco; M Lombardi; R Fiorentino; L Varricchio; M V Barone; F Auricchio
Journal:  EMBO J       Date:  2001-11-01       Impact factor: 11.598

6.  BRCA1 transcriptionally regulates genes involved in breast tumorigenesis.

Authors:  Piri L Welcsh; Ming K Lee; Rachel M Gonzalez-Hernandez; Daniel J Black; Mamatha Mahadevappa; Elizabeth M Swisher; Janet A Warrington; Mary-Claire King
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

7.  Angiocidin inhibits breast cancer proliferation through activation of epidermal growth factor receptor and nuclear factor kappa (NF-ĸB).

Authors:  Jessica Godek; Irene Sargiannidou; Sneha Patel; Lauren Hurd; Vicki L Rothman; George P Tuszynski
Journal:  Exp Mol Pathol       Date:  2011-01-15       Impact factor: 3.362

8.  Expression of the estrogen receptor gene in developing and adult human breast.

Authors:  M Boyd; R H Hildebrandt; S A Bartow
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

9.  Involvement of protein kinase C-dependent mitogen-activated protein kinase p44/42 signaling pathway for cross-talk between estradiol and transforming growth factor-beta3 in increasing basic fibroblast growth factor in folliculostellate cells.

Authors:  Kirti Chaturvedi; Dipak K Sarkar
Journal:  Endocrinology       Date:  2003-11-06       Impact factor: 4.736

Review 10.  Preclinical pharmacological profile of nomegestrol acetate, a synthetic 19-nor-progesterone derivative.

Authors:  Harry A van Diepen
Journal:  Reprod Biol Endocrinol       Date:  2012-10-08       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.